Entera Bio Ltd
|Market Cap (Intraday)||120.78M|
|2yr Forward PE||N/A|
Entera Bio Ltd Stock, NASDAQ:ENTX
Entera Bio Ltd. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of orally delivered large molecule therapeutics. It develops an oral formulation of parathyroid hormone. The company was founded on June 1, 2010 and is headquartered in Jerusalem, Israel.